X0609 4 2026-09-10 0001438533 Travere Therapeutics, Inc. TVTX 0001506916 Meckler Jeffrey A false C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DR., SUITE 300 SAN DIEGO CA 92130 true false false false 1 Common Stock 2026-09-10 4 M 0 10000 17.44 A 101500 D Common Stock 2026-09-10 4 M 0 10000 26.52 A 111500 D Common Stock 2026-09-10 4 S 0 1700 65.3917 D 109800 D Common Stock 2026-09-10 4 S 0 1200 66.15 D 108600 D Common Stock 2026-09-10 4 S 0 14000 67.4634 D 94600 D Common Stock 2026-09-10 4 S 0 3100 68.088 D 91500 D Stock option (right to buy) 17.44 2026-09-10 4 M 0 10000 0 D 2027-05-17 Common Stock 10000 0 D Stock option (right to buy) 26.52 2026-09-10 4 M 0 10000 0 D 2028-05-09 Common Stock 10000 0 D This sale was made pursuant to a written plan adopted on June 11, 2026 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying stock options granted to the Reporting Person on May 17, 2017, with an expiration date of May 17, 2027, and on May 9, 2018, with an expiration date of May 9, 2028. The weighted average sale price for the transaction reported was $65.3917, and the range of prices were between $64.835 and $65.81. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. The weighted average sale price for the transaction reported was $66.15, and the range of prices were between $65.93 and $66.74. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. The weighted average sale price for the transaction reported was $67.4634, and the range of prices were between $66.93 and $67.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. The weighted average sale price for the transaction reported was $68.088, and the range of prices were between $67.94 and $68.23. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. The stock option is fully vested and exercisable. /s/ Elizabeth E. Reed, Attorney-in-Fact 2026-09-11